• HOME
  • Technology
  • Pipeline

Drug Efficacy Assay

Advantages of Tumoroid-Based Platform
  • By producing tumoroid (cancer avatar) that retain key characteristics of their tissue of origin in vitro, it is possible to create a model that accurately reflects the patient's tissue and genetic characteristics, and that can be proliferated by generating tumoroid-lines
  • Excellent accuracy and expendability compared with existing platforms
TDEA (Tumoroid drug efficacy assay)
  • In OncoCelw’s tumoroid biobank, the test group can be selected based on the types of cancer origins, genotypes, and phenotypes desired by sponsor, and drug efficacy assay is carried out by OncoClew expert research team